Apoptosis, a morphologically de®ned form of physiological cell death, is implemented by a death machinery whose executionary arm is a family of cysteine proteases called caspases. These death proteases are part of a proteolytic caspase cascade that is activated by diverse apoptotic stimuli from outside and inside of the cell. The cell death machinery is evolutionarily conserved and composed of caspases and their regulatory components that include activators and repressors. These key components of the death machinery are linked to signaling pathways that are activated by either ligation of death receptors expressed at the cell surface or intracellular death signals. Caspases are normally present in the cell as proenzymes that require limited proteolysis for activation of enzymatic activity. Recent studies suggest that the basic mechanism of caspase activation is conserved in evolution. Binding of initiator caspase precursors to activator molecules appears to promote procaspase oligomerization and autoactivation. Enzymatic activation of initiator caspases leads to proteolytic activation of downstream (eector) caspases and cleavage of a number of vital proteins, resulting in the orderly demise and removal of the cell.
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Keywords: apoptosis; Bcl-2; caspase; cell death; protease Caspases: structure and classi®cation Apoptosis, a process of cell suicide critical for development and tissue homeostasis, is controlled by an evolutionarily conserved program. The uniform morphological features observed in apoptotic cells from dierent organisms suggest that a common mechanism may operate to trigger the execution of the cell. Genetic analyses in the nematode Caenorhabditis elegans have identi®ed two genes, ced-3 and ced-4, that are required for the execution of the cell death process (Yuan and Horvitz, 1992; Yuan et al., 1993) . The cloning of ced-3, a gene that encodes a protease with homology to mammalian interleukin-1b-converting enzyme, provided the ®rst indication that cysteine proteases are critical components of the cell death machinery (Yuan et al., 1993) . This observation lead to the identi®cation of a growing family of cysteine proteases with homology to CED-3 that have been designated caspases . To date, more than 14 caspases have been cloned and partially characterized in mammals and many, but not all, have been implicated in the apoptosis process. These cysteine proteases are synthesized in the cell as inactive precursors composed of four distinct domains: an amino-terminal domain of variable size (termed N-terminal polypeptide or prodomain), a large subunit, a small subunit, and a linker region between the large and small domains¯anked by Asp residues (reviewed in Nicholson and . Activation of each caspase is induced by proteolytic cleavage between domains, resulting in the removal of the prodomain and linker regions, and assembly of the large and small subunits into an active enzyme complex. Crystal structure analyses of caspase-1 and caspase-3 bound to substrate analogues have revealed that active caspases are composed of two heterodimers interacting via the small subunits to form a tretramer with two catalytic sites (Walker et al., 1994; Wilson et al., 1994; Rotonda et al., 1996) . Each active site is formed by sequences contributed by both the large and small subunits, providing amino acids necessary for substrate recognition and catalysis.
Despite their shared requirement for cleavage after aspartate acid residues at the substrate P1 site, caspases are highly speci®c in their substrate preferences. The substrate speci®city is largely determined by the sequence of four amino acids amino-terminal to the substrate P1 site, with P4, which binds to a conserved site in the small subunit, being the most critical determinant of speci®city (Talanian et al., 1997; Thornberry et al., 1997) . Caspase precursors are activated by proteolytic processing at internal caspase recognition sites, suggesting that caspases can process themselves and/or other precursor caspases to generate active enzymes in vivo (Nicholson and . In this respect, caspases function in a proteolytic cascade that is reminiscent of the cascade observed during the activation of blood coagulation factors.
The mammalian cell death proteases have been divided into upstream (initiator) and downstream (eector) caspases based on the their sites of action in the proteolytic caspase cascade. In addition, caspases have dierent prodomains. Initiator caspases, but not eector caspases, have long prodomains containing structurally related protein modules that physically link these proteases to their speci®c activators (Table 1) . Two types of interaction modules have been detected in the prodomains of initiator caspases: death eector domain (DED) or caspase recruitment domain (CARD) (Boldin et al., 1996; Muzio et al., 1996; Homan et al., 1997) . Nematode CED-3 and mammalian caspase-1, -2, -4, -5, -8, -9, -10, -11, -12 and -13 have prodomains with DEDs or CARDs. In contrast, caspase-3, -6, -7 and -14 have short prodomains. DEDs and CARDs in certain procaspases physically connect the initiator caspases with critical regulatory molecules via homophilic interactions. The role of initiator and eector caspases in the proteolytic cascade is consistent with the optimal recognition motifs of these caspases. Initiator caspases have substrate speci®cities that are similar to caspase recognition sites present in their own sequence , implying that these caspases can utilize autocatalysis for activation. Moreover, optimal caspase recognition sites for initiator caspases are present in the sequence of several eector proenzymes including procaspase-3 and procaspase-7, suggesting that these enzymes act downstream of initiator caspases in the proteolytic cascade .
Caspases play a critical role in the execution of apoptosis
Genetic analysis of the nematode C. elegans has provided direct evidence that caspases are required for developmental cell death. In the worm, loss-offunction mutations of ced-3 prevent almost all the cell deaths that normally occur during development (Ellis and Horvitz, 1986; Yuan et al., 1993) . In mammals, caspases are activated by a variety of apoptotic stimuli, and the apoptotic process is largely suppressed by caspase inhibitors, suggesting that caspases are required for the execution of apoptosis (Nicholson and . However, the role of individual caspases in apoptosis remains unclear, as the analysis is complicated by the existence of multiple caspases that are often co-expressed in the same tissues. The role of caspases in cell death has been revealed by the phenotype of mice de®cient in certain caspases. Targeted disruption of caspase-1, caspase-2 or caspase-11 has no or little eect on apoptosis in vivo (Kuida et al., 1995; Li et al., 1995; Bergeron et al., 1998; Wang et al., 1998) . In contrast, ablation of caspase-3, -8 or -9 by gene targeting has profound eects (Kuida et al., 1996 (Kuida et al., , 1998 Woo et al., 1998; Varfolomeev et al. 1998) .
Mice de®cient in caspase-8, a caspase linked to death receptors, exhibit abnormal heart development and die early during embryonic development . The majority of mutant mice de®cient in caspase-3 or caspase-9 die in utero and exhibit brain malformations caused by decreased apoptosis in the proliferative neuroepithelium (Kuida et al., 1996 (Kuida et al., , 1998 Woo et al., 1998; . Importantly, caspase-9 activates caspase-3 in vitro (Li et al., 1997) , and is required for activation of caspase-3 in the developing brain, implying that caspase-9 is an upstream activator of caspase-3 in vivo (Kuida et al., 1998) . The embryonic, or perinatal, death of caspase knockout mice has hampered the analysis of the role of these caspases in adult tissues. Studies of mouse embryonic ®broblasts (MEFs) derived from caspase-8 de®cient mice showed that this caspase is required for apoptosis induced by TNF receptors, Fas and DR3, but not several stimuli that arise from outside and inside the cell including serum deprivation, ceramide, and chemotherapeutic agents . Conversely, caspase-9 appears to play an important role in MEF apoptosis induced by dexamethasone, chemotherapeutic agents, and girradiation, but not in apoptosis activated by death receptor stimulation (Kuida et al., 1998; . The activation of caspases has been implicated in thymic selection (Clayton et al., 1997) , however, caspase-3 and caspase-9 are dispensable for apoptosis that occurs during T cell selection in the thymus (Kuida et al., 1996 (Kuida et al., , 1998 . Therefore, the role of caspases in mammalian apoptosis is complex in that multiple caspases may have redundant functions or act in concert to execute the apoptotic process in a cell-speci®c and stimulusdependent manner (Woo et al., 1998; Bergeron et al., 1998; .
Analyses of mice de®cient in the caspase regulators, FADD and Apaf-1, have provided insight into the role of these proteins in apoptosis. Ablation of the caspase-8 regulator, FADD, is embryonic lethal with mutant mice exhibiting abnormalities similar to that observed in caspase-8 de®cient mice (Yeh et al. 1998; Zhang et al., 1998) . As was observed in caspase-8 mutant mice, cells de®cient in FADD are protected against apoptosis induced by Fas, TNFR1 and DR3 receptors (Yeh et al., 1998; Zhang et al., 1998) . These results are consistent with an obligatory role for the FADDcaspase-8 pathway in apoptosis mediated by these death receptors. Analysis of mice de®cient in the caspase-9 activator, Apaf-1, has revealed abnormalities in multiple tissues that are characterized by developmental cell death (Cecconi et al., 1998; Yoshida et al., 1998) . They include brain hyperplasia, craniofacial alterations, eye abnormalities, and persistence of interdigital webs. Signi®cantly, caspase-9 knockout mice exhibit similar abnormalities in the brain, which is consistent with a common Apaf-1-caspase-9 death pathway in the brain. However, the phenotype of Apaf-1 de®cient mice was more severe than that observed in caspase-9 knockout mice (Kuida et al., 1998; Cecconi et al., 1998; Yoshida et al., 1998) . Furthermore, Apaf-1 mutant mice exhibited abnormalities, such as persistence of interdigital webs, that were not observed in caspase-9-de®cient mice. These results suggest that Apaf-1 may regulate caspases other than caspase-9. These caspases might include other initiator caspases with CARD or Ced-3 ? Ced-4 Ced-9 Egl-l Caspase (2), 8, 9, 10 Caspase (2), 3, 4, 5, 6, 7, 11, 12, 13 Apaf
Role of caspases in apoptosis G Nun Äez et al DED domains in their prodomains, such as those which have been found to associate with Apaf-1 (Hu et al. 1998a) . Alternatively, Apaf-1 might have caspaseindependent functions or regulate other caspases indirectly through adaptor molecules. Another interesting result observed in the Apaf-1 knockout mice was the lack of apparent abnormalities in tissues, such as the thymus, whose appropriate cellular development depends on apoptosis (Surh and Sprent, 1994) . This might be explained by the existence of additional Apaf-1-like molecules or apoptosis pathways that are Apaf-1-independent.
Cellular targets of caspases
Cells undergoing apoptosis often display a number of characteristic biochemical and morphological changes such as DNA cleavage, chromatin condensation, loss of mitochondrial membrane potential, changes in plasma membrane composition, and formation of apoptotic bodies (Kerr et al., 1972; Wyllie et al., 1984; Martin et al., 1995; Zamzani et al., 1996) . Studies utilizing caspase inhibitors link caspase activation to a number of these observed changes (reviewed in Cohen, 1997) . The role of caspase-3 in this process has recently been clari®ed by data from caspase-3 knockout mice, in which some cells fail to display chromatin condensation or DNA degradation while undergoing cell death in vitro (Woo et al., 1998) . The structured dismantling of the cell during the executionary phase of apoptosis is a complex process likely involving the cleavage of a large number of cellular substrates by downstream eector caspases. Most caspase substrates can be divided into two general categories: (1) regulators of apoptosis which are either activated or inactivated by cleavage; and (2) housekeeping or structural proteins whose cleavage is required for the ordered disassembly of the cell. Cleavage and activation of proapoptotic substrates provide signals which can link the two dierent cascade programs or allow for positive feedback of apoptotic signals, thus enhancing the apoptotic process. The kinases MEK kinase 1, Mst1 and p21-activated kinase2/hPak65 are all cleaved and activated by caspases, resulting in potential feedback activation through c-Jun kinase/stress-activated protein kinase regulated portions of the apoptotic pathway (Cardone et al., 1997; Widmann et al., 1998a; Graves et al., 1998; Lee et al., 1997; Rudel and Bokoch, 1997) . caspase-8 cleavage of another proapoptotic substrate, the Bcl-2 family member Bid, triggers cytochrome C release from the mitochondria, conceivably linking the death receptor and the Apaf-1/Caspase 9 pathways . Similar cross-talk between the two pathways may also result from caspase-8 cleavage of the eector caspase-3, which can in turn cleave and activate caspase-9 . On the other hand, caspase cleavage and inhibition of proteins that relay survival and proliferation signals is also common in apoptosis. Such proteins include the phosphatidylinositol-3 kinase/Akt, Raf-1, and Focal Adhesion Kinase (Widmann et al., 1998b; Wen et al., 1997; Gervais et al., 1998; Levkau et al., 1998) . Ced-9, Bcl-2 and Bcl-x L , anti-apoptotic members of the Bcl-2 family, are also cleaved by caspases (Xue and Horvitz, 1997; Cheng et al., 1997; Clem et al., 1998; Grandgirard et al., 1998) . However, in vivo cleavage and inactivation of prosurvival function has only been reported for Bcl-2 and Bcl-x L . Interestingly, cleavage of Bcl-2 or Bcl-x L also produces a proapoptotic fragment that is potentially a positive feedback signal that enhances or accelerates the apoptotic process.
Cleavage of a number of structural or housekeeping proteins by caspases is thought to facilitate the disassembly of a cell undergoing apoptosis. For example, nuclear lamins, the major cytoskeletal structural component of the nucleus, are cleaved by caspase-6 during apoptosis (Lazebnik et al., 1995; Orth et al., 1996 , Rao et al., 1996 . The cytoskeletal protein actin, as well as a number of actin-regulatory proteins including a-fodrin, aII-and bII-spectrin, and gelsolin are also cleaved by caspases during apoptosis (Mashima et al., 1997; Brocksted et al., 1998; Cryns et al., 1996; JaÈ nicke et al., 1998 , Nath et al., 1996 Wang et al., 1998) . Not surprisingly, a number of proteins involved in DNA synthesis and repair, such as the nuclear replication factor MCM3, the large subunit of DNA replication factor C and human Rad51, have also been identi®ed as caspase substrates in cells undergoing apoptosis (RheÂ aume et al., 1997; Ubeda and Habener, 1997; Schwab et al., 1998; Flygare et al., 1998) . Moreover, the nuclease DFF40/CAD, which cleaves the DNA into internucleosomal fragments is activated during apoptosis by eector caspases (Liu et al., , 1998 Enari et al., 1998; Halenbeck et al., 1998) . Activation of this nuclease results from the caspase-3-mediated cleavage of its inhibitor, DFF45/ ICAD Sakahira et al., 1998) . Further proof of the role of caspase cleavage in this activation comes from experiments in which a cleavage-resistant mutant ICAD/DFF45 protects cells from internucleosomal DNA fragmentation and nuclear condensation, but not other apoptotic events such as changes in plasma membrane composition, loss of mitochondrial membrane potential or membrane blebbing Liu et al., 1998) . The use of such experiments in which caspase-resistant substrates are analysed for their eects on apoptosis will aid in the general validation of these proteins as active participants in this process.
Regulation of caspase activation
Initiator caspases are activated by a wide array of apoptotic signals. Two main caspase cascades have been delineated in mammalian cells (Figure 1) . The ®rst pathway links caspase-8 to death receptors expressed at the cell surface including Fas, TNFR1 and DR3. In the second pathway, caspase-9 is activated by a variety of death stimuli from both outside and inside the cell (Figure 1) . Active caspase-8 or caspase-9 can cleave and activate an overlapping set of eector caspases including caspase-3, -6, and -7, resulting in enhanced expression of protease activity in the cell (Takahashi et al., 1996; Faleiro et al. 1997; Li et al., 1997; Stennicke et al., 1998) .
How are the initiator caspases activated? Ligation of death receptors, such as Fas, by trimeric ligands induces the recruitment of FADD and procaspase-8 into a death-inducing signaling complex (DISC) (Medema et al., 1997) . This is mediated by the association of the death receptor with FADD via their respective death domains (DDs), and in some cases with TRADD, another DD-containing molecule (Boldin et al., 1995; Chinnaiyan et al., 1995) . Activation of procaspase-8 requires the interaction with its binding partner FADD via their respective DEDs (Boldin et al., 1996; Muzio et al., 1996; Medema et al., 1997) . There is mounting evidence that caspase-8 aggregation induces autoprocessing and procaspase-8 activation (Yang et al., 1998a; Muzio et al., 1998; Martin et al., 1998; MacCorkle et al., 1998) . In this model, FADD brings into proximity two or more procaspase-8 molecules, an event that might be sucient for procaspase-8 activation (Figure 2) .
Biochemical analyses of the nematode CED-4 protein have provided important clues about the mechanism of CED-3 activation. This worm caspase resembles mammalian initiator caspases, particularly procaspase-9, in that it contains a large prodomain with a CARD domain . Biochemical studies have shown that CED-4 physically interacts with CED-3 and promotes the proteolytic processing of immature CED-3 into enzymatically active subunits (Seshagiri and Miller, 1997; Wu et al., 1997b) . Recent biochemical experiments have suggested a conserved mechanism by which immature CED-3 is activated by CED-4. CED-4 selfassociates via an oligomerization domain located in the putative ATPase domain (Yang et al., 1998b) . The ATPase-like domain of CED-4 that mediates oligomerization has been designated here as NOD, after nucleotide-binding oligomerization domain. Activation of CED-3 is induced through oligomerization of CED-4, which is mediated by the NOD domain (Yang et al., 1998b) . In this model, the CARD of CED-4 recruits CED-3, and two or more CED-3 precursor molecules are brought into proximity through CED-4 oligomerization, resulting in CED-3 precursor aggregation, autoprocessing and activation.
Apaf-1, a mammalian homologue of CED-4, has been recently identi®ed . Apaf-1 shares extensive homology with CED-4 in that it contains conserved CARD and NOD domains . The C-terminal region of Apaf-1 lacks homology with CED-4 and is composed of 12 WD-40 repeats . Apaf-1 and procaspase-9 associate via their CARDs (Li et al., 1997) . The mechanism of procaspase-9 activation appears similar to that proposed for CED-3 Hu et al. 1998b ). In the case of procaspase-9, Apaf-1 oligomerization mediated by the NOD induces procaspase-9 autoactivation (Figure 2) .
One potential mechanism to control activation of these initiator caspases might involve inhibition of the Figure 1 Two main pathways of caspase activation. In the ®rst pathway, activation of initiator caspase-8 or caspase-10 is triggered by ligation of death receptors including Fas, TNFR1 and DR3 through the adaptor molecule FADD. In the second pathway, a variety of extracellular and intracellular death stimuli trigger the release of cytochrome c from mitochondria. Cytosolic cytochrome c binds to Apaf-1, and Apaf-1 promotes activation of procaspase-9 in the presence of dATP or ATP. Active caspase-8 and caspase-9 activate eector caspases such as caspase-3, -6 and -7. Active eector caspases mediate the cleavage of an overlapping set of protein substrates, resulting in morphological features of apoptosis and the demise of the cell. Caspase-8 has been shown to cleave Bid, a proapoptotic Bcl-2 family member. Cleaved Bid binds to mitochondria (presumably via its enhanced association with Bcl-x L ) and induces the release of cytochrome c. Thus, Bid links the caspase-8 and caspase-9 pathways interaction between procaspases and their activators. Indeed, v-FLIP (viral FADD-like ICE inhibitory protein), a DED-containing protein binds FADD and inhibits apoptosis (Bertin et al., 1997; Thome et al., 1997) . The function of a cellular homologue, c-FLIP L (also called by various names), is more complex since this protein contains a caspase-like domain that can self-associate and bind caspase-8, and because its expression can inhibit or promote apoptosis depending on the cellular setting (Shu et al., 1997; Irmler et al., 1997; Hu et al., 1997; Inohara et al., 1997; Srinivasula et al., 1997; Goltsev et al., 1997) . Another caspase regulator is ARC (apoptosis regulator with CARD) that associates with and inhibits several initiator procaspases (Koseki et al., 1998) .
Viruses can produce potent caspase inhibitors to attenuate apoptosis in infected cells. CrmA, a product of the cowpox virus binds and inhibits active caspases, most notably caspase-1 and caspase-8 (Zhou et al., 1997). The baculovirus p35 protein also bind and inhibits active caspases but with a broader range than CrmA (Bump et al., 1995; Bertin et al., 1996) . IAP proteins (inhibitors of apoptosis) are a family of caspase inhibitors that were identi®ed based on homology to baculovirus IAPs (Rothe et al., 1995; Roy et al., 1995; Liston et al., 1996; Duckett et al., 1996; Uren et al., 1996) . Certain cellular IAPs have been shown to repress apoptosis and to selectively inhibit eector caspases such as caspase-3 and caspase-7 Roy et al., 1997) . However, the mechanism of apoptosis inhibition remains unclear, as IAPs appear to act through several mechanisms to repress apoptosis Duckett et al., 1998) . Finally, the nematode CED-9 and its mamma- . The death domain (DD) of FADD binds to the corresponding DD located in the cytoplasmic region of the death receptor. FADD and procaspase-8 associate via their respective DED. In the model, FADD brings into close proximity two or more procaspase-8 molecules, a process that leads to caspase-8 self-activation. (B) Activation of procaspase-9. In the model, death signals from outside and inside the cell induce the release of cytochrome c from the mitochondria. Cytosolic cytochrome c binds to the WD40 repeats of Apaf-1, and in the presence of dATP or ATP, Apaf-1 binds to procaspase-9 via their respective CARD domains. In the model, Apaf-1 self-association mediated by its nucleotide-binding oligomerization domain (NOD) brings into proximity two or more procaspase-9 molecules, a process that promotes activation of procaspase-9 lian prosurvival homologues interact with and inhibit the activators CED-4 and Apaf-1, respectively, perhaps by controlling their oligomerization.
Cytochrome c as a regulator of caspase activation
The presence of WD-40 repeats in the C-terminal region of Apaf-1 is surprising in that these repeats are not present in its nematode homologue CED-4. The discovery that cytochrome c, a key component of the mitochondrial transport system, is required for the activation of caspase-3 was unexpected, but provided a new framework in which to understand caspase activation in mammalian cells (Liu et al., 1996) . We now know that cytochrome c is released from mitochondria in response to a variety of apoptotic stimuli, an event that promotes caspase activation (Kharbanda et al., 1997; Kluck et al., 1997) . In the cytosol, cytochrome c can bind Apaf-1 and in the presence of dATP or ATP, Apaf-1 adopts a conformation that enhances its ability to associate with procaspase-9 . Thus, the WD40 repeats might be important for the recognition of death signals via cytochrome c. The release of cytochrome c from mitochondria occurs upstream of caspase activity (Bossy-Wetzel et al., 1998) and is not impaired in Apaf-1 de®cient cells, consistent with a role for Apaf-1 downstream of cytochrome c release (Yoshida et al., 1998) . Although dATP/ATP is required for the activation of procaspase-9 by Apaf-1 , the role of dATP/ATP in Apaf-1 function and caspase-9 activation remains unclear. How is Apaf-1 regulated by cytochrome c and dATP? Mutant analyses of Apaf-1 have suggested that the WD40-repeat region plays an inhibitory role in Apaf-1 function, as deletion of these repeats results in a constitutively active Apaf-1 protein (Hu et al., 1998a; Srinivasula et al., 1998) . Recent experiments also suggest that the WD40-repeat region can associate with the N-terminal region of Apaf-1 and regulate Apaf-1 self-association (Hu et al., 1998b) . One conceivable model of Apaf-1 activation is that binding of cytochrome c and/or dATP induce a conformational change in Apaf-1 that disrupts an inhibitory interaction between the WD40-repeat and the N-terminal region (Hu et al., 1998b) . This might enable the activator Apaf-1 to bind procaspase-9 molecule, oligomerize and thus promote activation of procaspase-9 molecules.
Bcl-2 family members regulate caspase activation
Inhibition of CED-4 or Apaf-1 oligomerization might provide an eective mechanism for the control of caspase activation. Prosurvival members of the Bcl-2 family have been shown to regulate the activation of caspases, providing a mechanism by which these proteins may inhibit apoptosis Armstrong et al., 1996; Shimizu et al., 1996) . In the nematode C. elegans, CED-9 (a homologue of Bcl-2 and Bcl-x L ) interacts with CED-4 suggesting that CED-9 regulates cell death by binding to and inactivating CED-4 (Chinnaiyan et al., 1997; Wu et al., 1997a; Spector et al., 1997) . Furthermore, as we describe above, CED-4 associates with CED-3 and promotes its proteolytic activation, and this activation process is inhibited by CED-9 through a multimeric protein complex (Chinnaiyan et al.,1997; Wu et al., 1997b; Seshagiri and Miller, 1997) . CED-9 binds the NOD domain of CED-4, which is involved in CED-4 oligomerization, a process that leads to CED-3 aggregation and autoactivation (Yang et al., 1998b) . Recent analyses of the mammalian counterparts have revealed that Bcl-x L interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 (Pan et al., 1998; Hu et al., 1998a) , suggesting that the regulation of the central cell death machinery is conserved through evolution from nematodes to humans. Like their nematode homologue CED-9, prosurvival Bcl-2 family members might function by preventing oligomerization of CED-4-like molecules, a step that appears to be essential for procaspase-9 activation (Srinivassula et al., 1998; Hu et al., 1998b) . In addition, prosurvival Bcl-2 family members localized in the outer membrane of the mitochondria can inhibit the release of cytochrome c that is induced by speci®c apoptotic stimuli (Kluck et al., 1997; Yang et al., 1997) . This eect provides another mechanism by which anti-apoptotic Bcl-2 family members might inhibit caspase activation and apoptosis, as cytochrome c is required for Apaf-1 to bind to and activate procaspase-9 (Li et al., 1997) .
Another group of Bcl-2 family members promotes apoptosis (Table I ; reviewed in Adams and Cory, 1998) . To date, all death-promoting Bcl-2-related proteins have been shown to heterodimerize via their BH3 domains with Bcl-2, Bcl-x L , A1 or Mcl-1, suggesting that these molecules promote cell death, at least in part, by interacting with and antagonizing prosurvival Bcl-2 family members (Adams and Cory, 1998). Proapoptotic Bcl-2 family members can induce the activation of caspases . How do these proapoptotic Bcl-2 proteins kill cells? Recent analyses in C. elegans have identi®ed EGL-1, a nematode counterpart of proapoptotic Bcl-2 family members that binds to CED-9 (Conradt and Horvitz, 1998) . Genetic analyses revealed that egl-1 acts upstream of or in parallel to ced-4 and ced-3 and requires ced-9 to exert its eect on programmed cell death (Conradt and Horvitz, 1998) . Biochemical studies indicate that EGL-1 binding to CED-9 disrupts the association between CED-4 and CED-9, an activity that promotes CED-4-dependent processing of CED-3 (del Peso et al., 1998). As with the nematode EGL-1, its mammalian homologues Bak and Bik also inhibit the association of Apaf-1 with Bcl-x L (Pan et al., 1998) , suggesting a conserved mechanism by which proapoptotic Bcl-2 family members promote caspase activation and apoptosis. In addition, BH3-containing, proapoptotic proteins have been shown to link the Apaf-1/caspase-9 pathway to other apoptotic signaling pathways. Bid, a proapoptotic Bcl-2 family member, is a substrate of caspase-8 which upon cleavage, strongly interacts with Bcl-x L presumably at the surface of the mitochondria, resulting in release of cytochrome c and activation of the Apaf-1/caspase-9 pathway Luo et al., 1998) . Bax, another proapoptotic member of the Bcl-2 family, has also been shown to bind mitochondria and to induce cytochrome c release (Wolter et al., 1997; Jurgensmeier et al., 1998) . The crosstalk between death receptor and Apaf-1/caspase-9 cell death pathways via Bid may play a role in the Role of caspases in apoptosis G Nun Äez et al ampli®cation of caspase activation and may explain why prosurvival Bcl-2 family members can interfere in some settings with apoptosis induced by Fas or TNFR1 ligation (JaÈ aÈ tela et al., 1995; Schneider et al., 1997) . Finally, extracellular stimuli can eect caspase activation through proapoptotic Bcl-2 family members. Growth factors promotes the phosphorylation and inactivation of Bad through the Akt signaling pathway (Datta et al., 1997; del Peso et al., 1997) . The expression of proapoptotic Bcl-2 family members, such as Hrk/DP5, are upregulated following growth factor withdrawal (Imaizumi et al., 1997) . Both Bad and Hrk bind to Bcl-2 and Bcl-x L (Yang et al., 1995; Inohara et al., 1997) , interactions that inhibit the ability of these prosurvival proteins to antagonize the cell death machinery.
Future research
The identi®cation of caspases as critical components of the death machinery represents a major advance in our understanding of the cell death process. We are beginning to understand the role of key regulatory molecules such as Apaf-1 and cofactors such a cytochrome c in caspase activation. However, the answers to many remain unknown. These include the precise mechanism by which Bcl-2 family members promote or counter caspase activation, and how dierent signaling pathways from inside and outside the cells engage the mitochondria and promote cytochrome c release. While apoptosis induced by stimulation of death receptors, such as Fas, appears to be mediated exclusively by caspases Varfolomeev et al., 1998) , some stimuli, including chemotherapeutic drugs and certain endogenous proapoptotic proteins such as Bax or Bak, may activate cell death through caspase-dependent and caspase-independent mechanisms McCarthy et al., 1997) . Thus, we need to understand the nature of caspase-insensitive cell death mechanisms that may operate in mammalian cells. Analyses of knockout mice have revealed the importance of caspases and their regulators in shaping developmental processes. Yet, we know very little about how developmental signals engage the death machinery. Analyses of knockout mice have also provided evidence for alternative pathways of caspase activation that need to be identi®ed and characterized. Finally, chemotherapeutic agents and other drugs that damage DNA induce caspase activation and apoptosis in part through a p53-dependent pathway. We do not understand how DNA damage and p53 engage the death machinery. The answers to these many questions may increase our ability to manipulate apoptosis for therapeutic purpose.
